About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...

A 2026 consumer research report examining LipoJaro's metabolic support claims, the viral "jello recipe gelatin trick" weight loss discussion, ingredient research context, and what consumers ...

Some people taking GLP-1 drugs experience a return of food noise and start putting pounds back on.

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

As part of an investigation that dates back to 2023, the FDA has identified over two dozen products featuring the plant.

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out. By Dani Blum Scientists raced to make drugs that help people lose as much weight as ...

Fact checked by Jennifer Klump Key Takeaways A phase 2 clinical trial found that combining semaglutide with the antibody ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...